| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| R&D Expense | $15.8M | +85.3% |
| SG&A Expense | $7.1M | +16.9% |
| Operating Income | -$31.8M | -148.5% |
| Net Income | -$31.6M | -147.6% |
| EPS (Basic) | -$14.88 | -4700.0% |
| EPS (Diluted) | -$14.88 | -4700.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12.1M | -58.6% |
| Current Assets | $14.5M | -51.9% |
| Total Assets | $14.7M | -64.1% |
| Total Liabilities | $4.3M | +102.1% |
| Stockholders' Equity | $10.4M | -73.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$17.6M | -72.5% |
| Investing Cash Flow | -$1.5M | — |
| Financing Cash Flow | $2.0M | -93.0% |